Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Retina Rumble: Debating Modern Treatment Options
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Yasha S. Modi, MD
Trends in PDR Treatments
Maria H. Berrocal, MD
Katharine Talcott, MD
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Hong-Uyen Hua, MD
Identifying Central and Branch Retinal Vein Occlusion
Jessica Randolph, MD
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Examining Therapeutic Timing in RVO-Related Macular Edema
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner
Vaidehi S. Dedania, MD
Rehan M. Hussain, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.